# Drug-drug Interaction Study Between UIC201603, and UIC201604

> **NCT06568133** · PHASE1 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 57 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** UIC201603 and co-administration of UIC201603 and UIC201604
- **DRUG:** UIC201604 and co-administration of UIC201603 and UIC201604

## Key facts

- **NCT ID:** NCT06568133
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-15
- **Primary completion:** 2017-07-04
- **Final completion:** 2018-02-07
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06568133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06568133, "Drug-drug Interaction Study Between UIC201603, and UIC201604". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06568133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*